跳至主要内容
临床试验/EUCTR2009-011324-60-DE
EUCTR2009-011324-60-DE进行中(未招募)不适用

Prospective randomized trial to compare a twice daily to a once daily administration of the Tacrolimus in lung transplanted patients - Advagraf-Study

Hannover Medical School0 个研究点目标入组 48 人开始时间: 2009年3月13日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
48

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Pts more than1 year after single lung, double lung or heart/lung transplantation and
  • Pts treated with ciclosporin, steroids and MMF and
  • Pts =18 and = 70 years and
  • Pts with one oft he following
  • Pts with recurrent acute rejections (RAR)
  • ?two or more acute rejections in 3 months (first 3 years post Tx,
  • 6 months (>3 years post Tx) defined by
  • transbronchial biopsy >A1 (or A1 with clinical criteria
  • below)nach ISHLT (B>1R) or
  • decline of FEV1 > 10 % baseline after exclusion of infection, airway complication, effusion etc. and improvement to steroid-pulse therapy (methylprednisolone 15 mg/kg for three days) = FEV1 improvement > 10% compared to the last measurement before AR treatment
  • Pts with steroid-resistant or ongoing acute rejections (OAR) defined by
  • ?transbronchial biopsy >A1 (or A1 with clinical criteria above) at
  • least 4 weeks following steroid-pulse therapy
  • (methylprednisolone 15 mg/kg for three days) or
  • ?no FEV1 improvement (< 5% baseline) at least 14 days
  • following ACR steroid-pulse therapy (methylprednisolone 15
  • mg/kg for three days) after exclusion of infection, airway
  • complication, effusion etc. or
  • Pts with new onset of BOS (nBOS)
  • Unexplained FEV1 < 80% of baseline after exclusion of
  • Infection, airway complication, effusion etc
  • Pts with CyA associated side effects (e.g. hyperlipidaemia,
  • hypertriglyceridemia, hypertension, hirsutism, gingival hyperplasia)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Pregnant or breast feeding women
  • Pts who are not using a double-barrier method of birth control
  • Pts with systemic infections
  • Pts with severe diarrhea, vomiting, active ulcer
  • Pts with severe liver disease or liver cirrhosis
  • Pts with m-Tor inhibitors
  • Pts with hypersensitivity to Tacrolimus, other macrolides or other tablet ingredients.

研究者

相似试验

Prospective randomized trial to compare a twice... | 临床试验